1 Primary Hepatocytes Market Overview
1.1 Product Overview and Scope of Primary Hepatocytes
1.2 Primary Hepatocytes Segment by Type
1.2.1 Global Primary Hepatocytes Market Value Comparison by Type (2023-2029)
1.2.2 Human Primary Cells
1.2.3 Animal Primary Cells
1.3 Primary Hepatocytes Segment by Application
1.3.1 Global Primary Hepatocytes Market Value by Application: (2023-2029)
1.3.2 Life Science Research Companies
1.3.3 Research Institutes
1.3.4 Others
1.4 Global Primary Hepatocytes Market Size Estimates and Forecasts
1.4.1 Global Primary Hepatocytes Revenue 2018-2029
1.4.2 Global Primary Hepatocytes Sales 2018-2029
1.4.3 Global Primary Hepatocytes Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Primary Hepatocytes Market Competition by Manufacturers
2.1 Global Primary Hepatocytes Sales Market Share by Manufacturers (2018-2023)
2.2 Global Primary Hepatocytes Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Primary Hepatocytes Average Price by Manufacturers (2018-2023)
2.4 Global Primary Hepatocytes Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Primary Hepatocytes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Primary Hepatocytes, Product Type & Application
2.7 Primary Hepatocytes Market Competitive Situation and Trends
2.7.1 Primary Hepatocytes Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Primary Hepatocytes Players Market Share by Revenue
2.7.3 Global Primary Hepatocytes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Primary Hepatocytes Retrospective Market Scenario by Region
3.1 Global Primary Hepatocytes Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Primary Hepatocytes Global Primary Hepatocytes Sales by Region: 2018-2029
3.2.1 Global Primary Hepatocytes Sales by Region: 2018-2023
3.2.2 Global Primary Hepatocytes Sales by Region: 2024-2029
3.3 Global Primary Hepatocytes Global Primary Hepatocytes Revenue by Region: 2018-2029
3.3.1 Global Primary Hepatocytes Revenue by Region: 2018-2023
3.3.2 Global Primary Hepatocytes Revenue by Region: 2024-2029
3.4 North America Primary Hepatocytes Market Facts & Figures by Country
3.4.1 North America Primary Hepatocytes Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Primary Hepatocytes Sales by Country (2018-2029)
3.4.3 North America Primary Hepatocytes Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Primary Hepatocytes Market Facts & Figures by Country
3.5.1 Europe Primary Hepatocytes Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Primary Hepatocytes Sales by Country (2018-2029)
3.5.3 Europe Primary Hepatocytes Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Primary Hepatocytes Market Facts & Figures by Country
3.6.1 Asia Pacific Primary Hepatocytes Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Primary Hepatocytes Sales by Country (2018-2029)
3.6.3 Asia Pacific Primary Hepatocytes Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Primary Hepatocytes Market Facts & Figures by Country
3.7.1 Latin America Primary Hepatocytes Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Primary Hepatocytes Sales by Country (2018-2029)
3.7.3 Latin America Primary Hepatocytes Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Primary Hepatocytes Market Facts & Figures by Country
3.8.1 Middle East and Africa Primary Hepatocytes Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Primary Hepatocytes Sales by Country (2018-2029)
3.8.3 Middle East and Africa Primary Hepatocytes Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Primary Hepatocytes Sales by Type (2018-2029)
4.1.1 Global Primary Hepatocytes Sales by Type (2018-2023)
4.1.2 Global Primary Hepatocytes Sales by Type (2024-2029)
4.1.3 Global Primary Hepatocytes Sales Market Share by Type (2018-2029)
4.2 Global Primary Hepatocytes Revenue by Type (2018-2029)
4.2.1 Global Primary Hepatocytes Revenue by Type (2018-2023)
4.2.2 Global Primary Hepatocytes Revenue by Type (2024-2029)
4.2.3 Global Primary Hepatocytes Revenue Market Share by Type (2018-2029)
4.3 Global Primary Hepatocytes Price by Type (2018-2029)
5 Segment by Application
5.1 Global Primary Hepatocytes Sales by Application (2018-2029)
5.1.1 Global Primary Hepatocytes Sales by Application (2018-2023)
5.1.2 Global Primary Hepatocytes Sales by Application (2024-2029)
5.1.3 Global Primary Hepatocytes Sales Market Share by Application (2018-2029)
5.2 Global Primary Hepatocytes Revenue by Application (2018-2029)
5.2.1 Global Primary Hepatocytes Revenue by Application (2018-2023)
5.2.2 Global Primary Hepatocytes Revenue by Application (2024-2029)
5.2.3 Global Primary Hepatocytes Revenue Market Share by Application (2018-2029)
5.3 Global Primary Hepatocytes Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific, Inc.
6.1.1 Thermo Fisher Scientific, Inc. Corporation Information
6.1.2 Thermo Fisher Scientific, Inc. Description and Business Overview
6.1.3 Thermo Fisher Scientific, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Thermo Fisher Scientific, Inc. Primary Hepatocytes Product Portfolio
6.1.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
6.2 Merck KGaA
6.2.1 Merck KGaA Corporation Information
6.2.2 Merck KGaA Description and Business Overview
6.2.3 Merck KGaA Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck KGaA Primary Hepatocytes Product Portfolio
6.2.5 Merck KGaA Recent Developments/Updates
6.3 Lonza
6.3.1 Lonza Corporation Information
6.3.2 Lonza Description and Business Overview
6.3.3 Lonza Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Lonza Primary Hepatocytes Product Portfolio
6.3.5 Lonza Recent Developments/Updates
6.4 Cell Biologics, Inc.
6.4.1 Cell Biologics, Inc. Corporation Information
6.4.2 Cell Biologics, Inc. Description and Business Overview
6.4.3 Cell Biologics, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cell Biologics, Inc. Primary Hepatocytes Product Portfolio
6.4.5 Cell Biologics, Inc. Recent Developments/Updates
6.5 PromoCell GmbH
6.5.1 PromoCell GmbH Corporation Information
6.5.2 PromoCell GmbH Description and Business Overview
6.5.3 PromoCell GmbH Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.5.4 PromoCell GmbH Primary Hepatocytes Product Portfolio
6.5.5 PromoCell GmbH Recent Developments/Updates
6.6 HemaCare Corporation
6.6.1 HemaCare Corporation Corporation Information
6.6.2 HemaCare Corporation Description and Business Overview
6.6.3 HemaCare Corporation Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.6.4 HemaCare Corporation Primary Hepatocytes Product Portfolio
6.6.5 HemaCare Corporation Recent Developments/Updates
6.7 ZenBio, Inc.
6.6.1 ZenBio, Inc. Corporation Information
6.6.2 ZenBio, Inc. Description and Business Overview
6.6.3 ZenBio, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.4.4 ZenBio, Inc. Primary Hepatocytes Product Portfolio
6.7.5 ZenBio, Inc. Recent Developments/Updates
6.8 STEMCELL Technologies, Inc.
6.8.1 STEMCELL Technologies, Inc. Corporation Information
6.8.2 STEMCELL Technologies, Inc. Description and Business Overview
6.8.3 STEMCELL Technologies, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.8.4 STEMCELL Technologies, Inc. Primary Hepatocytes Product Portfolio
6.8.5 STEMCELL Technologies, Inc. Recent Developments/Updates
6.9 Corning Incorporated
6.9.1 Corning Incorporated Corporation Information
6.9.2 Corning Incorporated Description and Business Overview
6.9.3 Corning Incorporated Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Corning Incorporated Primary Hepatocytes Product Portfolio
6.9.5 Corning Incorporated Recent Developments/Updates
6.10 AllCells
6.10.1 AllCells Corporation Information
6.10.2 AllCells Description and Business Overview
6.10.3 AllCells Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.10.4 AllCells Primary Hepatocytes Product Portfolio
6.10.5 AllCells Recent Developments/Updates
6.11 Axol Bioscience Ltd.
6.11.1 Axol Bioscience Ltd. Corporation Information
6.11.2 Axol Bioscience Ltd. Primary Hepatocytes Description and Business Overview
6.11.3 Axol Bioscience Ltd. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Axol Bioscience Ltd. Primary Hepatocytes Product Portfolio
6.11.5 Axol Bioscience Ltd. Recent Developments/Updates
6.12 iXCells Biotechnologies
6.12.1 iXCells Biotechnologies Corporation Information
6.12.2 iXCells Biotechnologies Primary Hepatocytes Description and Business Overview
6.12.3 iXCells Biotechnologies Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.12.4 iXCells Biotechnologies Primary Hepatocytes Product Portfolio
6.12.5 iXCells Biotechnologies Recent Developments/Updates
6.13 Neuromics
6.13.1 Neuromics Corporation Information
6.13.2 Neuromics Primary Hepatocytes Description and Business Overview
6.13.3 Neuromics Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Neuromics Primary Hepatocytes Product Portfolio
6.13.5 Neuromics Recent Developments/Updates
6.14 StemExpress
6.14.1 StemExpress Corporation Information
6.14.2 StemExpress Primary Hepatocytes Description and Business Overview
6.14.3 StemExpress Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.14.4 StemExpress Primary Hepatocytes Product Portfolio
6.14.5 StemExpress Recent Developments/Updates
6.15 BioIVT
6.15.1 BioIVT Corporation Information
6.15.2 BioIVT Primary Hepatocytes Description and Business Overview
6.15.3 BioIVT Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.15.4 BioIVT Primary Hepatocytes Product Portfolio
6.15.5 BioIVT Recent Developments/Updates
6.16 ScienCell Research Laboratories, Inc.
6.16.1 ScienCell Research Laboratories, Inc. Corporation Information
6.16.2 ScienCell Research Laboratories, Inc. Primary Hepatocytes Description and Business Overview
6.16.3 ScienCell Research Laboratories, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.16.4 ScienCell Research Laboratories, Inc. Primary Hepatocytes Product Portfolio
6.16.5 ScienCell Research Laboratories, Inc. Recent Developments/Updates
6.17 PPA Research Group, Inc.
6.17.1 PPA Research Group, Inc. Corporation Information
6.17.2 PPA Research Group, Inc. Primary Hepatocytes Description and Business Overview
6.17.3 PPA Research Group, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.17.4 PPA Research Group, Inc. Primary Hepatocytes Product Portfolio
6.17.5 PPA Research Group, Inc. Recent Developments/Updates
6.18 Creative Bioarray
6.18.1 Creative Bioarray Corporation Information
6.18.2 Creative Bioarray Primary Hepatocytes Description and Business Overview
6.18.3 Creative Bioarray Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Creative Bioarray Primary Hepatocytes Product Portfolio
6.18.5 Creative Bioarray Recent Developments/Updates
6.19 BPS Bioscience, Inc.
6.19.1 BPS Bioscience, Inc. Corporation Information
6.19.2 BPS Bioscience, Inc. Primary Hepatocytes Description and Business Overview
6.19.3 BPS Bioscience, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.19.4 BPS Bioscience, Inc. Primary Hepatocytes Product Portfolio
6.19.5 BPS Bioscience, Inc. Recent Developments/Updates
6.20 Epithelix Sàrl
6.20.1 Epithelix Sàrl Corporation Information
6.20.2 Epithelix Sàrl Primary Hepatocytes Description and Business Overview
6.20.3 Epithelix Sàrl Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Epithelix Sàrl Primary Hepatocytes Product Portfolio
6.20.5 Epithelix Sàrl Recent Developments/Updates
6.21 ReachBio LLC
6.21.1 ReachBio LLC Corporation Information
6.21.2 ReachBio LLC Primary Hepatocytes Description and Business Overview
6.21.3 ReachBio LLC Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.21.4 ReachBio LLC Primary Hepatocytes Product Portfolio
6.21.5 ReachBio LLC Recent Developments/Updates
6.22 AcceGen
6.22.1 AcceGen Corporation Information
6.22.2 AcceGen Primary Hepatocytes Description and Business Overview
6.22.3 AcceGen Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.22.4 AcceGen Primary Hepatocytes Product Portfolio
6.22.5 AcceGen Recent Developments/Updates
6.23 Sekisui XenoTech, LLC
6.23.1 Sekisui XenoTech, LLC Corporation Information
6.23.2 Sekisui XenoTech, LLC Primary Hepatocytes Description and Business Overview
6.23.3 Sekisui XenoTech, LLC Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Sekisui XenoTech, LLC Primary Hepatocytes Product Portfolio
6.23.5 Sekisui XenoTech, LLC Recent Developments/Updates
6.24 Biopredic International
6.24.1 Biopredic International Corporation Information
6.24.2 Biopredic International Primary Hepatocytes Description and Business Overview
6.24.3 Biopredic International Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Biopredic International Primary Hepatocytes Product Portfolio
6.24.5 Biopredic International Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Primary Hepatocytes Industry Chain Analysis
7.2 Primary Hepatocytes Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Primary Hepatocytes Production Mode & Process
7.4 Primary Hepatocytes Sales and Marketing
7.4.1 Primary Hepatocytes Sales Channels
7.4.2 Primary Hepatocytes Distributors
7.5 Primary Hepatocytes Customers
8 Primary Hepatocytes Market Dynamics
8.1 Primary Hepatocytes Industry Trends
8.2 Primary Hepatocytes Market Drivers
8.3 Primary Hepatocytes Market Challenges
8.4 Primary Hepatocytes Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Table 1. Global Primary Hepatocytes Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Primary Hepatocytes Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Primary Hepatocytes Market Competitive Situation by Manufacturers in 2022
Table 4. Global Primary Hepatocytes Sales (K MT) of Key Manufacturers (2018-2023)
Table 5. Global Primary Hepatocytes Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Primary Hepatocytes Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Primary Hepatocytes Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Primary Hepatocytes Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Primary Hepatocytes, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Primary Hepatocytes, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Primary Hepatocytes, Product Type & Application
Table 12. Global Key Manufacturers of Primary Hepatocytes, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Primary Hepatocytes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Hepatocytes as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Primary Hepatocytes Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Primary Hepatocytes Sales by Region (2018-2023) & (K MT)
Table 18. Global Primary Hepatocytes Sales Market Share by Region (2018-2023)
Table 19. Global Primary Hepatocytes Sales by Region (2024-2029) & (K MT)
Table 20. Global Primary Hepatocytes Sales Market Share by Region (2024-2029)
Table 21. Global Primary Hepatocytes Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Primary Hepatocytes Revenue Market Share by Region (2018-2023)
Table 23. Global Primary Hepatocytes Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Primary Hepatocytes Revenue Market Share by Region (2024-2029)
Table 25. North America Primary Hepatocytes Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Primary Hepatocytes Sales by Country (2018-2023) & (K MT)
Table 27. North America Primary Hepatocytes Sales by Country (2024-2029) & (K MT)
Table 28. North America Primary Hepatocytes Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Primary Hepatocytes Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Primary Hepatocytes Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Primary Hepatocytes Sales by Country (2018-2023) & (K MT)
Table 32. Europe Primary Hepatocytes Sales by Country (2024-2029) & (K MT)
Table 33. Europe Primary Hepatocytes Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Primary Hepatocytes Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Primary Hepatocytes Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Primary Hepatocytes Sales by Region (2018-2023) & (K MT)
Table 37. Asia Pacific Primary Hepatocytes Sales by Region (2024-2029) & (K MT)
Table 38. Asia Pacific Primary Hepatocytes Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Primary Hepatocytes Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Primary Hepatocytes Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Primary Hepatocytes Sales by Country (2018-2023) & (K MT)
Table 42. Latin America Primary Hepatocytes Sales by Country (2024-2029) & (K MT)
Table 43. Latin America Primary Hepatocytes Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Primary Hepatocytes Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Primary Hepatocytes Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Primary Hepatocytes Sales by Country (2018-2023) & (K MT)
Table 47. Middle East & Africa Primary Hepatocytes Sales by Country (2024-2029) & (K MT)
Table 48. Middle East & Africa Primary Hepatocytes Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Primary Hepatocytes Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Primary Hepatocytes Sales (K MT) by Type (2018-2023)
Table 51. Global Primary Hepatocytes Sales (K MT) by Type (2024-2029)
Table 52. Global Primary Hepatocytes Sales Market Share by Type (2018-2023)
Table 53. Global Primary Hepatocytes Sales Market Share by Type (2024-2029)
Table 54. Global Primary Hepatocytes Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Primary Hepatocytes Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Primary Hepatocytes Revenue Market Share by Type (2018-2023)
Table 57. Global Primary Hepatocytes Revenue Market Share by Type (2024-2029)
Table 58. Global Primary Hepatocytes Price (USD/MT) by Type (2018-2023)
Table 59. Global Primary Hepatocytes Price (USD/MT) by Type (2024-2029)
Table 60. Global Primary Hepatocytes Sales (K MT) by Application (2018-2023)
Table 61. Global Primary Hepatocytes Sales (K MT) by Application (2024-2029)
Table 62. Global Primary Hepatocytes Sales Market Share by Application (2018-2023)
Table 63. Global Primary Hepatocytes Sales Market Share by Application (2024-2029)
Table 64. Global Primary Hepatocytes Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Primary Hepatocytes Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Primary Hepatocytes Revenue Market Share by Application (2018-2023)
Table 67. Global Primary Hepatocytes Revenue Market Share by Application (2024-2029)
Table 68. Global Primary Hepatocytes Price (USD/MT) by Application (2018-2023)
Table 69. Global Primary Hepatocytes Price (USD/MT) by Application (2024-2029)
Table 70. Thermo Fisher Scientific, Inc. Corporation Information
Table 71. Thermo Fisher Scientific, Inc. Description and Business Overview
Table 72. Thermo Fisher Scientific, Inc. Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 73. Thermo Fisher Scientific, Inc. Primary Hepatocytes Product
Table 74. Thermo Fisher Scientific, Inc. Recent Developments/Updates
Table 75. Merck KGaA Corporation Information
Table 76. Merck KGaA Description and Business Overview
Table 77. Merck KGaA Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 78. Merck KGaA Primary Hepatocytes Product
Table 79. Merck KGaA Recent Developments/Updates
Table 80. Lonza Corporation Information
Table 81. Lonza Description and Business Overview
Table 82. Lonza Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 83. Lonza Primary Hepatocytes Product
Table 84. Lonza Recent Developments/Updates
Table 85. Cell Biologics, Inc. Corporation Information
Table 86. Cell Biologics, Inc. Description and Business Overview
Table 87. Cell Biologics, Inc. Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 88. Cell Biologics, Inc. Primary Hepatocytes Product
Table 89. Cell Biologics, Inc. Recent Developments/Updates
Table 90. PromoCell GmbH Corporation Information
Table 91. PromoCell GmbH Description and Business Overview
Table 92. PromoCell GmbH Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 93. PromoCell GmbH Primary Hepatocytes Product
Table 94. PromoCell GmbH Recent Developments/Updates
Table 95. HemaCare Corporation Corporation Information
Table 96. HemaCare Corporation Description and Business Overview
Table 97. HemaCare Corporation Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 98. HemaCare Corporation Primary Hepatocytes Product
Table 99. HemaCare Corporation Recent Developments/Updates
Table 100. ZenBio, Inc. Corporation Information
Table 101. ZenBio, Inc. Description and Business Overview
Table 102. ZenBio, Inc. Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 103. ZenBio, Inc. Primary Hepatocytes Product
Table 104. ZenBio, Inc. Recent Developments/Updates
Table 105. STEMCELL Technologies, Inc. Corporation Information
Table 106. STEMCELL Technologies, Inc. Description and Business Overview
Table 107. STEMCELL Technologies, Inc. Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 108. STEMCELL Technologies, Inc. Primary Hepatocytes Product
Table 109. STEMCELL Technologies, Inc. Recent Developments/Updates
Table 110. Corning Incorporated Corporation Information
Table 111. Corning Incorporated Description and Business Overview
Table 112. Corning Incorporated Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 113. Corning Incorporated Primary Hepatocytes Product
Table 114. Corning Incorporated Recent Developments/Updates
Table 115. AllCells Corporation Information
Table 116. AllCells Description and Business Overview
Table 117. AllCells Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 118. AllCells Primary Hepatocytes Product
Table 119. AllCells Recent Developments/Updates
Table 120. Axol Bioscience Ltd. Corporation Information
Table 121. Axol Bioscience Ltd. Description and Business Overview
Table 122. Axol Bioscience Ltd. Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 123. Axol Bioscience Ltd. Primary Hepatocytes Product
Table 124. Axol Bioscience Ltd. Recent Developments/Updates
Table 125. iXCells Biotechnologies Corporation Information
Table 126. iXCells Biotechnologies Description and Business Overview
Table 127. iXCells Biotechnologies Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 128. iXCells Biotechnologies Primary Hepatocytes Product
Table 129. iXCells Biotechnologies Recent Developments/Updates
Table 130. Neuromics Corporation Information
Table 131. Neuromics Description and Business Overview
Table 132. Neuromics Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 133. Neuromics Primary Hepatocytes Product
Table 134. Neuromics Recent Developments/Updates
Table 135. StemExpress Corporation Information
Table 136. StemExpress Description and Business Overview
Table 137. StemExpress Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 138. StemExpress Primary Hepatocytes Product
Table 139. StemExpress Recent Developments/Updates
Table 140. BioIVT Corporation Information
Table 141. BioIVT Description and Business Overview
Table 142. BioIVT Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 143. BioIVT Primary Hepatocytes Product
Table 144. BioIVT Recent Developments/Updates
Table 145. ScienCell Research Laboratories, Inc. Corporation Information
Table 146. ScienCell Research Laboratories, Inc. Description and Business Overview
Table 147. ScienCell Research Laboratories, Inc. Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 148. ScienCell Research Laboratories, Inc. Primary Hepatocytes Product
Table 149. ScienCell Research Laboratories, Inc. Recent Developments/Updates
Table 150. PPA Research Group, Inc. Corporation Information
Table 151. PPA Research Group, Inc. Description and Business Overview
Table 152. PPA Research Group, Inc. Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 153. PPA Research Group, Inc. Primary Hepatocytes Product
Table 154. PPA Research Group, Inc. Recent Developments/Updates
Table 155. Creative Bioarray Corporation Information
Table 156. Creative Bioarray Description and Business Overview
Table 157. Creative Bioarray Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 158. Creative Bioarray Primary Hepatocytes Product
Table 159. Creative Bioarray Recent Developments/Updates
Table 160. BPS Bioscience, Inc. Corporation Information
Table 161. BPS Bioscience, Inc. Description and Business Overview
Table 162. BPS Bioscience, Inc. Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 163. BPS Bioscience, Inc. Primary Hepatocytes Product
Table 164. BPS Bioscience, Inc. Recent Developments/Updates
Table 165. Epithelix Sàrl Corporation Information
Table 166. Epithelix Sàrl Description and Business Overview
Table 167. Epithelix Sàrl Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 168. Epithelix Sàrl Primary Hepatocytes Product
Table 169. Epithelix Sàrl Recent Developments/Updates
Table 170. ReachBio LLC Corporation Information
Table 171. ReachBio LLC Description and Business Overview
Table 172. ReachBio LLC Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 173. ReachBio LLC Primary Hepatocytes Product
Table 174. ReachBio LLC Recent Developments/Updates
Table 175. AcceGen Corporation Information
Table 176. AcceGen Description and Business Overview
Table 177. AcceGen Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 178. AcceGen Primary Hepatocytes Product
Table 179. AcceGen Recent Developments/Updates
Table 180. Sekisui XenoTech, LLC Corporation Information
Table 181. Sekisui XenoTech, LLC Description and Business Overview
Table 182. Sekisui XenoTech, LLC Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 183. Sekisui XenoTech, LLC Primary Hepatocytes Product
Table 184. Sekisui XenoTech, LLC Recent Developments/Updates
Table 185. Biopredic International Corporation Information
Table 186. Biopredic International Description and Business Overview
Table 187. Biopredic International Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 188. Biopredic International Primary Hepatocytes Product
Table 189. Biopredic International Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Primary Hepatocytes Distributors List
Table 193. Primary Hepatocytes Customers List
Table 194. Primary Hepatocytes Market Trends
Table 195. Primary Hepatocytes Market Drivers
Table 196. Primary Hepatocytes Market Challenges
Table 197. Primary Hepatocytes Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Primary Hepatocytes
Figure 2. Global Primary Hepatocytes Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Primary Hepatocytes Market Share by Type in 2022 & 2029
Figure 4. Human Primary Cells Product Picture
Figure 5. Animal Primary Cells Product Picture
Figure 6. Global Primary Hepatocytes Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Primary Hepatocytes Market Share by Application in 2022 & 2029
Figure 8. Life Science Research Companies
Figure 9. Research Institutes
Figure 10. Others
Figure 11. Global Primary Hepatocytes Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Primary Hepatocytes Market Size (2018-2029) & (US$ Million)
Figure 13. Global Primary Hepatocytes Sales (2018-2029) & (K MT)
Figure 14. Global Primary Hepatocytes Average Price (USD/MT) & (2018-2029)
Figure 15. Primary Hepatocytes Report Years Considered
Figure 16. Primary Hepatocytes Sales Share by Manufacturers in 2022
Figure 17. Global Primary Hepatocytes Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Primary Hepatocytes Players: Market Share by Revenue in 2022
Figure 19. Primary Hepatocytes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Primary Hepatocytes Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Primary Hepatocytes Sales Market Share by Country (2018-2029)
Figure 22. North America Primary Hepatocytes Revenue Market Share by Country (2018-2029)
Figure 23. United States Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Primary Hepatocytes Sales Market Share by Country (2018-2029)
Figure 26. Europe Primary Hepatocytes Revenue Market Share by Country (2018-2029)
Figure 27. Germany Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Primary Hepatocytes Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Primary Hepatocytes Revenue Market Share by Region (2018-2029)
Figure 34. China Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Primary Hepatocytes Sales Market Share by Country (2018-2029)
Figure 44. Latin America Primary Hepatocytes Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Primary Hepatocytes Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Primary Hepatocytes Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Primary Hepatocytes Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Primary Hepatocytes by Type (2018-2029)
Figure 54. Global Revenue Market Share of Primary Hepatocytes by Type (2018-2029)
Figure 55. Global Primary Hepatocytes Price (USD/MT) by Type (2018-2029)
Figure 56. Global Sales Market Share of Primary Hepatocytes by Application (2018-2029)
Figure 57. Global Revenue Market Share of Primary Hepatocytes by Application (2018-2029)
Figure 58. Global Primary Hepatocytes Price (USD/MT) by Application (2018-2029)
Figure 59. Primary Hepatocytes Value Chain
Figure 60. Primary Hepatocytes Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
